Sugi Predict
/ Targets
/ CDH1
Top predicted compounds (top 20 by supporting neighbours, then confidence)
Clinical trials — most relevant to CDH1 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Identifying Predictors Of Response To Mepolizumab In CRSwNP |
PHASE4 | RECRUITING |
| Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) |
PHASE2 | UNKNOWN |
| Avutometinib and Defactinib in Diffuse Gastric Cancer |
PHASE2 | RECRUITING |
| Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer |
PHASE2 | COMPLETED |
| Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer. |
PHASE2 | WITHDRAWN |
| Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn |
PHASE1 | COMPLETED |
| Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer |
PHASE1 | COMPLETED |
| Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors |
PHASE1 | UNKNOWN |
| KRAS Wild-type Metastatic Colorectal Cancer Trial |
PHASE1 | COMPLETED |
| Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study |
nan | COMPLETED |
| Expression of Epithelial-Mesenchymal Transition Associated Markers in Peri-implant Tissues |
nan | RECRUITING |
| Epithelial Mesenchymal Transition Markers in OSMF |
nan | COMPLETED |
| CircularRNA-microRNA-mRNA Regulatory Axis in IVF |
nan | NOT_YET_RECRUITING |
| Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family. |
nan | UNKNOWN |
| Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial |
nan | NOT_YET_RECRUITING |
| Cell Membrane Potential Regulates Spatial-Specific Mechanoptosis Resistance and Metastasis in Colorectal Cancer Via Mechanotransduction and the PVR/CD96 Axis |
nan | COMPLETED |
| CDH1 Germline Mutations in Lobular Breast Cancer |
nan | COMPLETED |
| Influence of EMT on CTCs and Disease Progression in Prostate Cancer |
nan | COMPLETED |
| CDH1-associated Blepharocheilodontic Syndrome Registry |
nan | RECRUITING |
| Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression |
nan | COMPLETED |
| Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry |
nan | ACTIVE_NOT_RECRUITING |
| Epithelial Mesenchymal Transition and Periodontitis |
nan | UNKNOWN |
| Early Onset and Familial Gastric Cancer Registry |
nan | COMPLETED |
| Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer |
nan | COMPLETED |
| Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA |
nan | RECRUITING |
| Role of Nox2 in CNI-induced Renal Fibrosis |
nan | COMPLETED |
| Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan |
nan | UNKNOWN |
| Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential |
nan | UNKNOWN |
| Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer |
nan | RECRUITING |
| Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a CDH1 binder may also engage these)